FOLD   $11.87  -1.17% Market Closed After Close 11.98 0.93%

Amicus Therapeutics Inc
Total Cash 260.06M
totalCashPerShare 0.877
EBITDA -16.68M
Total Debt 444.06M
quickRatio 2.054
currentRatio 2.747
Total Revenue 455.66M
debtToEquity 335.08
Revenue/Share 1.515
ROA -0.02148
ROE -0.97939
grossProfits
freeCashflow 12.99M
operatingCashflow -41.89M
earningsGrowth
revenueGrowth 0.34
grossMargins 0.89883006
ebitdaMargins -0.03661
operatingMargins 0.11816
profitMargins -0.26233998
enterpriseValue 3.71B
forwardPE 54.65909
floatShares 238.86M
sharesOutstanding 296.59M
sharesShort 21.74M
sharesShortPriorMonth 23.20M
dateShortInterest
sharesPercentSharesOut 0.07%
heldPercentInsiders 0.01%
heldPercentInstitutions 1.08%
Short Ratio help_outline 9.99%
shortPercentOfFloat 0.07%
impliedSharesOutstanding
bookValue 0.447
Price To Book help_outline 26.90
earningsQuarterlyGrowth
netIncomeToCommon -119.54M
trailingEps -0.39%
forwardEps 0.22%
enterpriseToEbitda -222.59
lastDividendValue
lastDividendDate
currentQuarterEstimate 0.0 3Q 2024
institutionsCount 351
lastUpdated Oct. 21, 2024, 10:24 p.m.